@Article{Minenna2022,
journal="Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii",
issn="1642-395X",
volume="39",
number="4",
year="2022",
title="Sustained drug-related reaction with eosinophilia and systemic symptoms (DRESS) triggered by low molecular weight heparins in COVID-19: management and precision diagnosis",
abstract="Low molecular weight heparins (LMWHs), particularly enoxaparin, are administered routinely to Coronavirus disease 2019 (COVID-19) patients, in order to treat or prevent the associated, possibly serious coagulation disorders [1].  Both immunoglobulin E (IgE)-mediated and non IgE-mediated systemic reactions to LMWHs are considered rare [2–4]. Particularly, a single case of the drug-related reaction with eosinophilia and systemic symptoms (DRESS) has been documented in the literature [4].  Here we report on an elderly COVID-19 patient who developed DRESS upon prophylactic treatment with enoxaparin. Etiological diagnosis was corroborated by the lymphocyte proliferation test (LPT) [5] upon recovery. The management strategy adopted is outlined and commented.",
author="Minenna, Elena
and Chaoul, Nada
and Pia Rossi, Maria
and Giliberti, Lucia
and Albanesi, Marcello
and Nettis, Eustachio
and Foschino Barbaro, Maria Pia
and Bona, Danilo Di
and Caiaffa, Maria Filomena
and Macchia, Luigi",
pages="816--818",
doi="10.5114/ada.2021.109586",
url="http://dx.doi.org/10.5114/ada.2021.109586"
}